CN102000319B - 一种暖胃舒乐片的制备方法 - Google Patents
一种暖胃舒乐片的制备方法 Download PDFInfo
- Publication number
- CN102000319B CN102000319B CN2010105643945A CN201010564394A CN102000319B CN 102000319 B CN102000319 B CN 102000319B CN 2010105643945 A CN2010105643945 A CN 2010105643945A CN 201010564394 A CN201010564394 A CN 201010564394A CN 102000319 B CN102000319 B CN 102000319B
- Authority
- CN
- China
- Prior art keywords
- parts
- medicinal materials
- corydalis
- nuanwei
- shule
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000002360 preparation method Methods 0.000 title claims description 21
- 239000000463 material Substances 0.000 claims abstract description 48
- 241000218176 Corydalis Species 0.000 claims abstract description 28
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims abstract description 23
- 239000000706 filtrate Substances 0.000 claims abstract description 11
- 238000000034 method Methods 0.000 claims abstract description 7
- 238000001035 drying Methods 0.000 claims abstract description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 37
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 claims description 31
- 241000304195 Salvia miltiorrhiza Species 0.000 claims description 28
- 235000011135 Salvia miltiorrhiza Nutrition 0.000 claims description 28
- 244000223760 Cinnamomum zeylanicum Species 0.000 claims description 27
- 241000202807 Glycyrrhiza Species 0.000 claims description 27
- 235000017803 cinnamon Nutrition 0.000 claims description 27
- 235000006533 astragalus Nutrition 0.000 claims description 25
- 241001127714 Amomum Species 0.000 claims description 24
- 241001061264 Astragalus Species 0.000 claims description 23
- 210000004233 talus Anatomy 0.000 claims description 23
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 claims description 22
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 claims description 22
- 241000249820 Lipotes vexillifer Species 0.000 claims description 22
- 229940010454 licorice Drugs 0.000 claims description 22
- 239000000203 mixture Substances 0.000 claims description 11
- 241000287828 Gallus gallus Species 0.000 claims description 9
- 244000184734 Pyrus japonica Species 0.000 claims description 9
- 239000002253 acid Substances 0.000 claims description 7
- 239000000047 product Substances 0.000 claims description 7
- 239000009636 Huang Qi Substances 0.000 claims description 6
- 239000008187 granular material Substances 0.000 claims description 6
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 claims description 5
- DCXXMTOCNZCJGO-UHFFFAOYSA-N Glycerol trioctadecanoate Natural products CCCCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCC DCXXMTOCNZCJGO-UHFFFAOYSA-N 0.000 claims description 5
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims description 5
- 238000001914 filtration Methods 0.000 claims description 5
- LTINPJMVDKPJJI-UHFFFAOYSA-N iodinated glycerol Chemical compound CC(I)C1OCC(CO)O1 LTINPJMVDKPJJI-UHFFFAOYSA-N 0.000 claims description 5
- 229910052749 magnesium Inorganic materials 0.000 claims description 5
- 239000011777 magnesium Substances 0.000 claims description 5
- 241000195474 Sargassum Species 0.000 claims description 2
- 239000012141 concentrate Substances 0.000 claims description 2
- 239000000796 flavoring agent Substances 0.000 claims 2
- 235000019634 flavors Nutrition 0.000 claims 2
- 208000007882 Gastritis Diseases 0.000 abstract description 8
- 208000023652 chronic gastritis Diseases 0.000 abstract description 8
- 210000004185 liver Anatomy 0.000 abstract description 8
- 208000007107 Stomach Ulcer Diseases 0.000 abstract description 7
- 230000007812 deficiency Effects 0.000 abstract description 7
- 208000000718 duodenal ulcer Diseases 0.000 abstract description 7
- 201000005917 gastric ulcer Diseases 0.000 abstract description 7
- 210000000952 spleen Anatomy 0.000 abstract description 7
- 238000004519 manufacturing process Methods 0.000 abstract description 6
- 210000002784 stomach Anatomy 0.000 abstract description 5
- 238000010792 warming Methods 0.000 abstract description 5
- 244000273928 Zingiber officinale Species 0.000 abstract description 3
- 235000006886 Zingiber officinale Nutrition 0.000 abstract description 3
- 235000008397 ginger Nutrition 0.000 abstract description 3
- 238000009495 sugar coating Methods 0.000 abstract description 3
- 241001313855 Bletilla Species 0.000 abstract description 2
- 240000003152 Rhus chinensis Species 0.000 abstract description 2
- 235000014220 Rhus chinensis Nutrition 0.000 abstract description 2
- 244000141331 Amomum villosum Species 0.000 abstract 1
- 244000037364 Cinnamomum aromaticum Species 0.000 abstract 1
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 abstract 1
- 235000021511 Cinnamomum cassia Nutrition 0.000 abstract 1
- 244000303040 Glycyrrhiza glabra Species 0.000 abstract 1
- 235000017443 Hedysarum boreale Nutrition 0.000 abstract 1
- 235000007858 Hedysarum occidentale Nutrition 0.000 abstract 1
- 244000047734 Paederia foetida Species 0.000 abstract 1
- 235000019116 Paederia foetida Nutrition 0.000 abstract 1
- 244000170916 Paeonia officinalis Species 0.000 abstract 1
- 235000006484 Paeonia officinalis Nutrition 0.000 abstract 1
- 229940107666 astragalus root Drugs 0.000 abstract 1
- 239000001947 glycyrrhiza glabra rhizome/root Substances 0.000 abstract 1
- 230000002040 relaxant effect Effects 0.000 abstract 1
- 210000003296 saliva Anatomy 0.000 abstract 1
- 238000007873 sieving Methods 0.000 abstract 1
- 230000003393 splenic effect Effects 0.000 abstract 1
- 239000003826 tablet Substances 0.000 description 36
- 230000000694 effects Effects 0.000 description 20
- 239000003814 drug Substances 0.000 description 19
- 239000004480 active ingredient Substances 0.000 description 15
- 238000000605 extraction Methods 0.000 description 15
- 229940079593 drug Drugs 0.000 description 13
- 230000001737 promoting effect Effects 0.000 description 12
- 239000002994 raw material Substances 0.000 description 12
- 238000012360 testing method Methods 0.000 description 11
- 208000002193 Pain Diseases 0.000 description 9
- 238000004458 analytical method Methods 0.000 description 4
- 230000017531 blood circulation Effects 0.000 description 4
- 230000007774 longterm Effects 0.000 description 4
- 239000006187 pill Substances 0.000 description 4
- 241000721047 Danaus plexippus Species 0.000 description 3
- 206010015137 Eructation Diseases 0.000 description 3
- 241000287826 Gallus Species 0.000 description 3
- 238000000540 analysis of variance Methods 0.000 description 3
- QMNWISYXSJWHRY-YLNUDOOFSA-N astragaloside IV Chemical group O1[C@H](C(C)(O)C)CC[C@]1(C)[C@@H]1[C@@]2(C)CC[C@]34C[C@]4(CC[C@H](O[C@H]4[C@@H]([C@@H](O)[C@H](O)CO4)O)C4(C)C)[C@H]4[C@@H](O[C@H]4[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O4)O)C[C@H]3[C@]2(C)C[C@@H]1O QMNWISYXSJWHRY-YLNUDOOFSA-N 0.000 description 3
- QMNWISYXSJWHRY-BCBPIKMJSA-N astragaloside IV Natural products CC(C)(O)[C@@H]1CC[C@@](C)(O1)[C@H]2[C@@H](O)C[C@@]3(C)[C@@H]4C[C@H](O[C@@H]5O[C@H](CO)[C@H](O)[C@@H](O)[C@H]5O)[C@H]6C(C)(C)[C@H](CC[C@@]67C[C@@]47CC[C@]23C)O[C@@H]8OC[C@@H](O)[C@H](O)[C@H]8O QMNWISYXSJWHRY-BCBPIKMJSA-N 0.000 description 3
- 208000027687 belching Diseases 0.000 description 3
- PFKIBRPYVNVMRU-UHFFFAOYSA-N cyclosieversioside F Natural products CC(C)(O)C1COC(C)(C1)C2C(O)CC3(C)C4CC(OC5OC(CO)C(O)C(O)C5O)C6C(C)(C)C(CCC67CC47CCC23C)OC8OCC(O)C(O)C8O PFKIBRPYVNVMRU-UHFFFAOYSA-N 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 238000004090 dissolution Methods 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 238000003304 gavage Methods 0.000 description 3
- 238000005469 granulation Methods 0.000 description 3
- 230000003179 granulation Effects 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 206010000060 Abdominal distension Diseases 0.000 description 2
- 206010000087 Abdominal pain upper Diseases 0.000 description 2
- 206010067484 Adverse reaction Diseases 0.000 description 2
- 241000045403 Astragalus propinquus Species 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 244000236658 Paeonia lactiflora Species 0.000 description 2
- 235000008598 Paeonia lactiflora Nutrition 0.000 description 2
- 241000700159 Rattus Species 0.000 description 2
- 206010067171 Regurgitation Diseases 0.000 description 2
- 230000006838 adverse reaction Effects 0.000 description 2
- 238000011888 autopsy Methods 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- 238000012795 verification Methods 0.000 description 2
- SNKFFCBZYFGCQN-UHFFFAOYSA-N 2-[3-[3-[1-carboxy-2-(3,4-dihydroxyphenyl)ethoxy]carbonyl-2-(3,4-dihydroxyphenyl)-7-hydroxy-2,3-dihydro-1-benzofuran-4-yl]prop-2-enoyloxy]-3-(3,4-dihydroxyphenyl)propanoic acid Chemical group C=1C=C(O)C=2OC(C=3C=C(O)C(O)=CC=3)C(C(=O)OC(CC=3C=C(O)C(O)=CC=3)C(O)=O)C=2C=1C=CC(=O)OC(C(=O)O)CC1=CC=C(O)C(O)=C1 SNKFFCBZYFGCQN-UHFFFAOYSA-N 0.000 description 1
- KSDSYIXRWHRPMN-UHFFFAOYSA-N 4'-O-beta-D-Galactopyranoside-6''-p-Coumaroylprunin-4',5,7-Trihydroxyflavanone Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(C2OC3=CC(O)=CC(O)=C3C(=O)C2)C=C1 KSDSYIXRWHRPMN-UHFFFAOYSA-N 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 102000003712 Complement factor B Human genes 0.000 description 1
- 108090000056 Complement factor B Proteins 0.000 description 1
- 208000018522 Gastrointestinal disease Diseases 0.000 description 1
- 206010020565 Hyperaemia Diseases 0.000 description 1
- DEMKZLAVQYISIA-ONJCETCRSA-N Liquiritin Natural products O([C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1)c1ccc([C@@H]2Oc3c(C(=O)C2)ccc(O)c3)cc1 DEMKZLAVQYISIA-ONJCETCRSA-N 0.000 description 1
- DEMKZLAVQYISIA-UHFFFAOYSA-N Liquirtin Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(C2OC3=CC(O)=CC=C3C(=O)C2)C=C1 DEMKZLAVQYISIA-UHFFFAOYSA-N 0.000 description 1
- SNKFFCBZYFGCQN-VWUOOIFGSA-N Lithospermic acid B Natural products C([C@H](C(=O)O)OC(=O)\C=C\C=1C=2[C@H](C(=O)O[C@H](CC=3C=C(O)C(O)=CC=3)C(O)=O)[C@H](OC=2C(O)=CC=1)C=1C=C(O)C(O)=CC=1)C1=CC=C(O)C(O)=C1 SNKFFCBZYFGCQN-VWUOOIFGSA-N 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 208000007101 Muscle Cramp Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- YKRGDOXKVOZESV-WRJNSLSBSA-N Paeoniflorin Chemical group C([C@]12[C@H]3O[C@]4(O)C[C@](O3)([C@]1(C[C@@H]42)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)C)OC(=O)C1=CC=CC=C1 YKRGDOXKVOZESV-WRJNSLSBSA-N 0.000 description 1
- 244000131316 Panax pseudoginseng Species 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 208000008469 Peptic Ulcer Diseases 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 1
- 231100000403 acute toxicity Toxicity 0.000 description 1
- 230000007059 acute toxicity Effects 0.000 description 1
- 238000011047 acute toxicity test Methods 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 238000009534 blood test Methods 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 231100000132 chronic toxicity testing Toxicity 0.000 description 1
- 230000013872 defecation Effects 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 208000010643 digestive system disease Diseases 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 239000008298 dragée Substances 0.000 description 1
- 210000001198 duodenum Anatomy 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 210000001156 gastric mucosa Anatomy 0.000 description 1
- 208000021302 gastroesophageal reflux disease Diseases 0.000 description 1
- 208000018685 gastrointestinal system disease Diseases 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 210000004209 hair Anatomy 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 238000009592 kidney function test Methods 0.000 description 1
- 238000011031 large-scale manufacturing process Methods 0.000 description 1
- 238000002386 leaching Methods 0.000 description 1
- 231100000518 lethal Toxicity 0.000 description 1
- 230000001665 lethal effect Effects 0.000 description 1
- DEMKZLAVQYISIA-ZRWXNEIDSA-N liquiritin Chemical group O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C([C@H]2OC3=CC(O)=CC=C3C(=O)C2)C=C1 DEMKZLAVQYISIA-ZRWXNEIDSA-N 0.000 description 1
- 238000007449 liver function test Methods 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 230000037257 muscle growth Effects 0.000 description 1
- 239000002547 new drug Substances 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- YKRGDOXKVOZESV-UHFFFAOYSA-N paeoniflorin Natural products O1C(C)(C2(CC34)OC5C(C(O)C(O)C(CO)O5)O)CC3(O)OC1C24COC(=O)C1=CC=CC=C1 YKRGDOXKVOZESV-UHFFFAOYSA-N 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 208000011906 peptic ulcer disease Diseases 0.000 description 1
- 230000000737 periodic effect Effects 0.000 description 1
- 230000000306 recurrent effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000001020 rhythmical effect Effects 0.000 description 1
- STCJJTBMWHMRCD-UHFFFAOYSA-N salvianolic acid B Natural products OC(=O)C(Cc1ccc(O)c(O)c1)OC(=O)C=Cc2cc(O)c(O)c3OC(C(C(=O)OC(Cc4ccc(O)c(O)c4)C(=O)O)c23)c5ccc(O)c(O)c5 STCJJTBMWHMRCD-UHFFFAOYSA-N 0.000 description 1
- 238000013077 scoring method Methods 0.000 description 1
- GSZUGBAEBARHAW-UHFFFAOYSA-N sophoraflavone B Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(C=2OC3=CC(O)=CC=C3C(=O)C=2)C=C1 GSZUGBAEBARHAW-UHFFFAOYSA-N 0.000 description 1
- 238000013112 stability test Methods 0.000 description 1
- 239000007940 sugar coated tablet Substances 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 235000019640 taste Nutrition 0.000 description 1
- 229940126585 therapeutic drug Drugs 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 238000010200 validation analysis Methods 0.000 description 1
- 230000009278 visceral effect Effects 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Description
Claims (3)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2010105643945A CN102000319B (zh) | 2010-11-29 | 2010-11-29 | 一种暖胃舒乐片的制备方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2010105643945A CN102000319B (zh) | 2010-11-29 | 2010-11-29 | 一种暖胃舒乐片的制备方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN102000319A CN102000319A (zh) | 2011-04-06 |
| CN102000319B true CN102000319B (zh) | 2012-04-25 |
Family
ID=43808189
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2010105643945A Active CN102000319B (zh) | 2010-11-29 | 2010-11-29 | 一种暖胃舒乐片的制备方法 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102000319B (zh) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104833735A (zh) * | 2015-04-23 | 2015-08-12 | 昆明生达制药有限公司 | 暖胃舒乐片的含量测定方法 |
| CN105561131A (zh) * | 2016-01-19 | 2016-05-11 | 苏州富欧生物科技有限公司 | 一种暖胃健胃中药制剂 |
| CN108815461A (zh) * | 2018-09-19 | 2018-11-16 | 廖增祥 | 一种治疗肠胃病的中药配方及其制备方法 |
-
2010
- 2010-11-29 CN CN2010105643945A patent/CN102000319B/zh active Active
Also Published As
| Publication number | Publication date |
|---|---|
| CN102000319A (zh) | 2011-04-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2007009291A1 (en) | A pharmaceutical composition of traditional chineses medicine for treating rheumatoid arthritis and preparation thereof | |
| CN102370751A (zh) | 一种治疗前列腺增生的中药复方制剂及其制备方法 | |
| CN104338044A (zh) | 治疗妇科白带异常的药物及其制备方法 | |
| CN102000319B (zh) | 一种暖胃舒乐片的制备方法 | |
| CN101856405A (zh) | 一种治疗2型糖尿病的药物组合物及其制备方法 | |
| CN102657736B (zh) | 一种治疗类风湿性关节炎的药物组合物及其制备方法 | |
| CN105688034A (zh) | 一种中药组合物在制备治疗胆囊切除术后综合征的药物中的应用 | |
| CN108721431B (zh) | 一种排重金属的中药组合物及其应用 | |
| CN103638135B (zh) | 清浊益肾胶囊 | |
| CN106620475A (zh) | 一种防治糖尿病认知障碍的中药组合物及制备方法 | |
| CN105878559A (zh) | 一种具有润肠通便功效的药物组合物或保健食品 | |
| CN106511634A (zh) | 一种治疗痛风的中药组合物及其制备方法 | |
| CN102000131B (zh) | 一种消癌平片的制备方法 | |
| CN102114189A (zh) | 一种治疗糖尿病的超微粒中药降糖片 | |
| CN103830653A (zh) | 一种用于治疗小儿迁延性腹泻的纯中药制剂及其制备方法 | |
| CN101011562A (zh) | 参芪温胆汤新剂型及其生产方法 | |
| CN103386055B (zh) | 一种前列安通胶囊及制备方法 | |
| CN102526664A (zh) | 一种治疗脾胃不和、脘腹胀痛的药物 | |
| CN108079089B (zh) | 一种治疗糖尿病肾病的中药组合物及其制备方法 | |
| CN104147229B (zh) | 一种治疗女性更年期综合征肾阴阳两虚型的中药复方制剂 | |
| CN118767070B (zh) | 一种用于补肾解毒的中药组合物、其浓缩丸的制备方法及用途 | |
| CN104399036A (zh) | 一种治疗慢性腹泻的药物组合物及其应用 | |
| CN103845447B (zh) | 一种具有益气健脾养肝、养血养心安神功能的纯中药养生制剂 | |
| CN117243995B (zh) | 一种治疗慢性肾衰的中药组合物及其制备方法和应用 | |
| CN101264208A (zh) | 用于治疗胃肠功能紊乱的药物组合物及其制备方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| ASS | Succession or assignment of patent right |
Owner name: GUANGDONG SHANGRUIHE PHARMACEUTICAL CO., LTD. Free format text: FORMER OWNER: YANGLING WUWEI PHARMACEUTICAL CO., LTD. Effective date: 20140130 |
|
| COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 712100 XI'AN, SHAANXI PROVINCE TO: 528437 ZHONGSHAN, GUANGDONG PROVINCE |
|
| TR01 | Transfer of patent right |
Effective date of registration: 20140130 Address after: 528437, No. 6, six Yue Jing Road, Torch Development Zone, Guangdong, Zhongshan Patentee after: GUANGDONG SHANGRUIHE PHARMACEUTICAL CO., LTD. Address before: 712100 No. 8 Shennong Road, Yangling demonstration area, Xi'an, Shaanxi Patentee before: Yangling Wuwei Pharmaceutical Group Co., Ltd. |
|
| TR01 | Transfer of patent right | ||
| C56 | Change in the name or address of the patentee | ||
| CP02 | Change in the address of a patent holder |
Address after: 528437 Guangdong province Zhongshan Nanlang town Southern China city of modern Chinese medicine Simiao Road No. 7 Patentee after: GUANGDONG SHANGRUIHE PHARMACEUTICAL CO., LTD. Address before: 528437, No. 6, six Yue Jing Road, Torch Development Zone, Guangdong, Zhongshan Patentee before: GUANGDONG SHANGRUIHE PHARMACEUTICAL CO., LTD. |
|
| C56 | Change in the name or address of the patentee | ||
| CP03 | Change of name, title or address |
Address after: 528400 Guangdong province Zhongshan Nanlang town Southern China city of modern Chinese medicine Simiao Road No. 7 Patentee after: GUANGDONG SINOTAU PHARMACEUTICAL CO., LTD. Address before: 528437 Guangdong province Zhongshan Nanlang town Southern China city of modern Chinese medicine Simiao Road No. 7 Patentee before: GUANGDONG SHANGRUIHE PHARMACEUTICAL CO., LTD. |